Gross Profit On Sales Cambio Fecha
AbbVie USD 9.56B 95M 2023-09
Acadia Pharmaceuticals USD 213.15M 16.07M 2023-12
Agios Pharmaceuticals USD 6.52M 249K 2023-12
Alnylam Pharmaceuticals USD 353.86M 312.36M 2023-12
Amgen USD 5.08B 14M 2023-12
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bluebird Bio USD 1.44M 4.11M 2023-09
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Gilead Sciences USD 5.5B 18M 2023-12
Incyte USD 949.29M 84.66M 2023-12
Insmed USD 65.25M 2.88M 2023-12
Ionis Pharmaceuticals USD 321.44M 179.43M 2023-12
J&J USD 14.6B 374M 2023-12
Merck USD 11.29B 441M 2023-12
Moderna USD 1.88B 2.29B 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
PTC Therapeutics USD 277.94M 90.85M 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Roche Holding CHF 22.16B 123M 2023-06
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
United Therapeutics USD 543.7M 4.4M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Vertex Pharmaceuticals Beneficio Bruto En Ventas - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.